ATI Total Cost of Revenue decreased by 1.7% to $888.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $908.60M to $888.60M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 9.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $573.50M | $643.20M | $643.20M | $664.70M | $784.20M | $848.20M | $824.70M | $844.90M | $836.90M | $831.00M | $858.30M | $845.50M | $867.90M | $826.40M | $924.10M | $908.60M | $897.90M | $870.20M | $903.70M | $888.60M |
| QoQ Change | — | +12.2% | +0.0% | +3.3% | +18.0% | +8.2% | -2.8% | +2.4% | -0.9% | -0.7% | +3.3% | -1.5% | +2.6% | -4.8% | +11.8% | -1.7% | -1.2% | -3.1% | +3.8% | -1.7% |
| YoY Change | — | — | — | — | +36.7% | +31.9% | +28.2% | +27.1% | +6.7% | -2.0% | +4.1% | +0.1% | +3.7% | -0.6% | +7.7% | +7.5% | +3.5% | +5.3% | -2.2% | -2.2% |